We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

20 hedge funds and large institutions have $1.81M invested in Coeptis Therapeutics Warrants in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less funds holding

Funds holding: 21 → 20 (-1)

36% less capital invested

Capital invested by funds: $2.82M → $1.81M (-$1M)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
4
Closed
2
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
+$5K

Top Buyers

Rank Fund Capital Flow
1
BCM
Basso Capital Management
Connecticut
+$60.2K
2
CL
CSS LLC
Illinois
+$3.9K

Top Sellers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$49K
2
GCL
Glazer Capital LLC
New York
-$33.5K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$6K
4
PC
Periscope Capital
Ontario, Canada
-$5.7K
5
ICM
Ionic Capital Management
New York
-$3.31K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$745K – – –
GCL
2
Glazer Capital LLC
New York
$208K -$33.5K -88,205 -10%
Citadel Advisors
3
Citadel Advisors
Florida
$155K – – –
BFM
4
Boothbay Fund Management
New York
$149K – – –
BCM
5
Basso Capital Management
Connecticut
$119K +$60.2K +158,452 +53%
ICM
6
Ionic Capital Management
New York
$111K -$3.31K -8,702 -2%
KC
7
Kepos Capital
New York
$65K – – –
OCAM
8
Owl Creek Asset Management
New York
$51K – – –
RCM
9
Rivernorth Capital Management
Florida
$39K – – –
Wells Fargo
10
Wells Fargo
California
$39K – – –
AA
11
AQR Arbitrage
Connecticut
$34K – – –
SCM
12
Shaolin Capital Management
Florida
$27K – – –
PC
13
Periscope Capital
Ontario, Canada
$23K -$5.7K -15,000 -14%
CAC
14
Cowen and Company
New York
$21K – – –
Walleye Trading
15
Walleye Trading
New York
$15K – – –
CL
16
CSS LLC
Illinois
$5K +$3.9K +10,268 New
KJHP
17
K.J. Harrison & Partners
Ontario, Canada
$4K – – –
PCM
18
Prelude Capital Management
New York
$4K – – –
Walleye Capital
19
Walleye Capital
New York
$23 – – –
Hudson Bay Capital Management
20
Hudson Bay Capital Management
Connecticut
– -$49K -90,962 Closed
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
– -$6K -11,382 Closed
UBS Group
22
UBS Group
Switzerland
– -$2.62K -6,883 -92%

COEPW Hedge Fund Activity: Q3 2021 in Review

20 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q3 2021, worth a combined $1.81M — down 36% from $2.82M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of COEPW and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.

The largest buyer was Basso Capital Management, adding an estimated $60.2K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $49K sold.

  • 20 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q3 2021, down from 21 in Q2 2021.
  • Funds reported $1.81M of Coeptis Therapeutics Warrants stock for Q3 2021, down 36% quarter-over-quarter.
  • 1 fund opened new Coeptis Therapeutics Warrants positions in Q3 2021 and 2 closed out, a net change of -1 holder.
  • The largest Coeptis Therapeutics Warrants buyer in Q3 2021 was Basso Capital Management, an estimated $60.2K added.
  • The largest Coeptis Therapeutics Warrants seller in Q3 2021 was Hudson Bay Capital Management, an estimated $49K sold.

Based on aggregated 13F filings for Q3 2021.